HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma.

AuthorsWarren P Mason
JournalNeuro-oncology (Neuro Oncol) Vol. 17 Issue 5 Pg. 634-5 (May 2015) ISSN: 1523-5866 [Electronic] England
PMID25681307 (Publication Type: Editorial, Comment)
Chemical References
  • Antineoplastic Agents
  • Snake Venoms
  • Tumor Suppressor Proteins
  • DNA Modification Methylases
  • DNA Repair Enzymes
Topics
  • Antineoplastic Agents (therapeutic use)
  • Brain Neoplasms (drug therapy)
  • DNA Modification Methylases (genetics)
  • DNA Repair Enzymes (genetics)
  • Female
  • Glioblastoma (drug therapy)
  • Humans
  • Male
  • Snake Venoms (therapeutic use)
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: